clinical trial transdermal glp-1 patch A Closer Look at the Dermatological Profile of Agonists Do GLP Patches Work? The

Patients must also consider the financial implications, as off-label use may not be NHS-funded, potentially incurring substantial private costs

Bouter et al., 2019

Results vary, and not every patient is a candidate for treatment

8 12

The peptide enhances metabolic flexibilitythe capacity to switch between carbohydrate and fat oxidationwhich is crucial for optimal body composition

As reported in the Diabetes Atlas (11th Edition) published by the International Diabetes Federation (2025), 589 million adults around the world are estimated to be living with diabetes mellitus (DM), with forecasts suggesting that this figure could increase to 853 million by 2050 (1)